Abbott Laboratories (ABT) Liabilities and Shareholders Equity (2009 - 2026)
Abbott Laboratories recorded quarterly Liabilities and Shareholders Equity of $110.4 billion in Q1 2026, up 27.35% quarter-over-quarter from $86.7 billion in Q4 2025, and up 35.58% year-over-year from $81.4 billion in Q1 2025.
Abbott Laboratories' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $110.4 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 35.58% year-over-year to $110.4 billion; the TTM figure through Mar 2026 stood at $365.3 billion (up 17.76% YoY), while the FY2025 annual figure was $86.7 billion, up 6.51% from the prior year.
- Liabilities and Shareholders Equity came in at $110.4 billion for Q1 2026 at Abbott Laboratories, up from $86.7 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $110.4 billion in Q1 2026 to a low of $2.9 billion in Q4 2022.
- A 5-year average of $74.4 billion and a median of $74.0 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity plunged 60.29% in 2022 and surged 2439.51% in 2023, its largest moves.
- Abbott Laboratories' Liabilities and Shareholders Equity stood at $2.9 billion in 2022, then soared by 2439.51% to $73.2 billion in 2023, then gained by 11.2% to $81.4 billion in 2024, then grew by 6.51% to $86.7 billion in 2025, then rose by 27.35% to $110.4 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $110.4 billion, $86.7 billion, and $84.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.43 Bn |
| Dec 31, 2025 | 86.71 Bn |
| Sep 30, 2025 | 84.18 Bn |
| Jun 30, 2025 | 84.00 Bn |
| Mar 31, 2025 | 81.45 Bn |
| Dec 31, 2024 | 81.41 Bn |
| Sep 30, 2024 | 74.36 Bn |
| Jun 30, 2024 | 73.02 Bn |
| Mar 31, 2024 | 72.47 Bn |
| Dec 31, 2023 | 73.21 Bn |
| Sep 30, 2023 | 72.09 Bn |
| Jun 30, 2023 | 73.35 Bn |
| Mar 31, 2023 | 73.79 Bn |
| Dec 31, 2022 | 2.88 Bn |
| Sep 30, 2022 | 72.80 Bn |
| Jun 30, 2022 | 74.20 Bn |
| Mar 31, 2022 | 74.01 Bn |
| Dec 31, 2021 | 7.26 Bn |
| Sep 30, 2021 | 73.80 Bn |
| Jun 30, 2021 | 73.27 Bn |
| Mar 31, 2021 | 72.79 Bn |
| Dec 31, 2020 | 2.89 Bn |
| Sep 30, 2020 | 69.04 Bn |
| Jun 30, 2020 | 68.78 Bn |
| Mar 31, 2020 | 66.78 Bn |
| Dec 31, 2019 | 5.24 Bn |
| Sep 30, 2019 | 68.54 Bn |
| Jun 30, 2019 | 68.43 Bn |
| Mar 31, 2019 | 67.61 Bn |
| Dec 31, 2018 | 67.17 Bn |
| Sep 30, 2018 | 71.64 Bn |
| Jun 30, 2018 | 68.42 Bn |
| Mar 31, 2018 | 70.91 Bn |
| Dec 31, 2017 | 76.25 Bn |
| Sep 30, 2017 | 72.25 Bn |
| Jun 30, 2017 | 71.15 Bn |
| Mar 31, 2017 | 70.89 Bn |
| Dec 31, 2016 | 52.67 Bn |
| Sep 30, 2016 | 39.50 Bn |
| Jun 30, 2016 | 39.83 Bn |
| Mar 31, 2016 | 39.64 Bn |
| Dec 31, 2015 | 41.25 Bn |
| Sep 30, 2015 | 41.73 Bn |
| Jun 30, 2015 | 44.13 Bn |
| Mar 31, 2015 | 43.10 Bn |
| Dec 31, 2014 | 41.21 Bn |
| Sep 30, 2014 | 42.51 Bn |
| Jun 30, 2014 | 41.48 Bn |
| Mar 31, 2014 | 41.66 Bn |
| Dec 31, 2013 | 42.94 Bn |
| Sep 30, 2013 | 44.13 Bn |
| Jun 30, 2013 | 42.90 Bn |
| Mar 31, 2013 | 42.69 Bn |
| Dec 31, 2012 | 67.24 Bn |
| Sep 30, 2012 | 63.26 Bn |
| Jun 30, 2012 | 61.86 Bn |
| Mar 31, 2012 | 62.42 Bn |
| Dec 31, 2011 | 60.28 Bn |
| Sep 30, 2011 | 59.63 Bn |
| Jun 30, 2011 | 62.00 Bn |
| Mar 31, 2011 | 61.65 Bn |
| Dec 31, 2010 | 60.57 Bn |
| Sep 30, 2010 | 57.37 Bn |
| Jun 30, 2010 | 53.38 Bn |
| Dec 31, 2009 | 52.58 Bn |
| Sep 30, 2009 | 49.85 Bn |
| Jun 30, 2009 | 47.63 Bn |